Search Results - "Clinical drug investigation"
-
1
Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review
Published in Clinical drug investigation (01-08-2018)“…The process of finding new therapeutic indications for currently used drugs, defined as ‘repurposing’, is receiving growing attention. Chloroquine and…”
Get full text
Journal Article -
2
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
Published in Clinical drug investigation (01-06-2020)“…Since December 2019, a novel coronavirus pneumonia (COVID-19) has broken out in Wuhan, China and spread rapidly. Recent studies have found that ⁓ 15.7% of…”
Get full text
Journal Article -
3
The Safety of Melatonin in Humans
Published in Clinical drug investigation (01-03-2016)“…Exogenous melatonin has been investigated as treatment for a number of medical and surgical diseases, demonstrating encouraging results. The aim of this review…”
Get full text
Journal Article -
4
Azithromycin for COVID-19: More Than Just an Antimicrobial?
Published in Clinical drug investigation (01-08-2020)“…Most of them evaluate established antiviral drugs such as lopinavir/ritonavir, and chloroquine (CQ) or its derivative hydroxychloroquine (HCQ), which have…”
Get full text
Journal Article -
5
An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease-19 (COVID-19)
Published in Clinical drug investigation (01-07-2020)“…Background and Objective The world is currently experiencing the Coronavirus Disease-19 (COVID-19) pandemic. There is no approved drug for the definitive…”
Get full text
Journal Article -
6
Adverse Event Profiles of Anti-CTLA-4 and Anti-PD-1 Monoclonal Antibodies Alone or in Combination: Analysis of Spontaneous Reports Submitted to FAERS
Published in Clinical drug investigation (01-03-2019)“…Background and Objective Immune checkpoint inhibitors (ICIs)—cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed death receptor-1 (PD-1) monoclonal…”
Get full text
Journal Article -
7
Management of Left Ventricular Thrombi with Direct Oral Anticoagulants: Retrospective Comparative Study with Vitamin K Antagonists
Published in Clinical drug investigation (01-04-2020)“…Background and Objectives The efficacy of direct oral anticoagulants (DOACs) in the management of left ventricular (LV) thrombi remains to be determined,…”
Get full text
Journal Article -
8
Impact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study
Published in Clinical drug investigation (01-10-2021)“…Background The efficacy of biological therapies used for the treatment of chronic plaque psoriasis can be influenced by numerous variables including body mass…”
Get full text
Journal Article -
9
The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
Published in Clinical drug investigation (01-05-2021)“…Although expanding the availability of buprenorphine—a first-line pharmacotherapy for opioid-use disorder (OUD)—has increased the capacity of healthcare…”
Get full text
Journal Article -
10
Riboflavin in Neurological Diseases: A Narrative Review
Published in Clinical drug investigation (01-06-2021)“…Riboflavin is classified as one of the water-soluble B vitamins. It is part of the functional group of flavin mononucleotide (FMN) and flavin adenine…”
Get full text
Journal Article -
11
Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19
Published in Clinical drug investigation (01-03-2021)“…Introduction Chlorpromazine has been suggested as being potentially useful in patients with coronavirus disease 2019 (COVID-19) on the grounds of its potential…”
Get full text
Journal Article -
12
Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment
Published in Clinical drug investigation (01-12-2019)“…Background and Objective Immunotherapy could change the complex host-microbial interactions. We aimed to investigate the dynamics of gut microbiome in response…”
Get full text
Journal Article -
13
Safety, Tolerability, and Pharmacokinetics of the Novel Anti-influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings
Published in Clinical drug investigation (01-12-2018)“…Background and Objective Baloxavir marboxil, a prodrug that is metabolized to baloxavir acid, suppresses viral replication by inhibiting cap-dependent…”
Get full text
Journal Article -
14
Lecanemab: More Questions Than Answers
Published in Clinical drug investigation (2024)“…The approval of lecanemab by the US Food and Drug Administration has been touted as a defining moment in the treatment of Alzheimer’s disease. Lecanemab, an…”
Get full text
Journal Article -
15
Glucagon-Like Peptide-1 Receptor Analogues in Type 2 Diabetes: Their Use and Differential Features
Published in Clinical drug investigation (01-08-2019)“…Glucagon-like peptide-1 receptor analogues/agonists (GLP-1RAs) are well established as effective adjuncts to lifestyle modification in the treatment of type 2…”
Get full text
Journal Article -
16
Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects
Published in Clinical drug investigation (01-04-2021)“…Background and Objectives Second-generation antipsychotics (SGAs) for schizophrenia show different risk profiles, whose evidence has been evaluated through…”
Get full text
Journal Article -
17
Real-Life Experience of Tralokinumab for the Treatment of Adult Patients with Severe Atopic Dermatitis: A Multicentric Prospective Study
Published in Clinical drug investigation (01-04-2023)“…Background Tralokinumab, the first fully human monoclonal antibody that binds specifically to interleukin-13, was safe and effective for treating atopic…”
Get full text
Journal Article -
18
The Respimat® Soft Mist Inhaler: Implications of Drug Delivery Characteristics for Patients
Published in Clinical drug investigation (01-11-2019)“…Successful treatment for respiratory diseases relies on effective delivery of medication to the lungs using an inhalation device. Different inhalers have…”
Get full text
Journal Article -
19
Paxlovid-Tacrolimus Drug–Drug Interaction in a 23-Year-Old Female Kidney Transplant Patient with COVID-19
Published in Clinical drug investigation (01-08-2022)“…Kidney transplant patients are at a high risk for adverse severe acute respiratory syndrome coronavirus 2 (SARSCOV-2) infection outcomes in terms of morbidity…”
Get full text
Journal Article -
20
Cannabidiol in the Treatment of Epilepsy
Published in Clinical drug investigation (01-03-2021)“…Anecdotal reports addressing the successful seizure treatment of severe epilepsies with cannabidiol (CBD) have increased both public interest and academic…”
Get full text
Journal Article